These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16817756)

  • 41. Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.
    Flynn CT; Kimura T; Frimpong-Boateng K; Harkins S; Whitton JL
    Virology; 2017 Dec; 512():104-112. PubMed ID: 28950225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
    Weller AH; Simpson K; Herzum M; Van Houten N; Huber SA
    J Immunol; 1989 Sep; 143(6):1843-50. PubMed ID: 2550544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D; Rose NR
    Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmunity in coxsackievirus B3 induced myocarditis.
    Huber SA
    Autoimmunity; 2006 Feb; 39(1):55-61. PubMed ID: 16455582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. From infection to autoimmunity.
    Fairweather D; Kaya Z; Shellam GR; Lawson CM; Rose NR
    J Autoimmun; 2001 May; 16(3):175-86. PubMed ID: 11334481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis.
    Fairweather D; Frisancho-Kiss S; Rose NR
    Rev Med Virol; 2005; 15(1):17-27. PubMed ID: 15386590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transition from viral to autoimmune myocarditis.
    Hill SL; Rose NR
    Autoimmunity; 2001; 34(3):169-76. PubMed ID: 11908774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Group B coxsackievirus virulence.
    Tracy S; Gauntt C
    Curr Top Microbiol Immunol; 2008; 323():49-63. PubMed ID: 18357765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Micronutrients and host resistance to viral infection.
    Beck MA; Matthews CC
    Proc Nutr Soc; 2000 Nov; 59(4):581-5. PubMed ID: 11115793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients.
    Gaaloul I; Riabi S; Harrath R; Hunter T; Hamda KB; Ghzala AB; Huber S; Aouni M
    Mol Med Rep; 2014 Dec; 10(6):2811-8. PubMed ID: 25241846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A molecular and serologic evaluation of enteroviral involvement in human myocarditis.
    Tracy S; Chapman NM; McManus BM; Pallansch MA; Beck MA; Carstens J
    J Mol Cell Cardiol; 1990 Apr; 22(4):403-14. PubMed ID: 2167382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic complexity of autoimmune myocarditis.
    Li HS; Ligons DL; Rose NR
    Autoimmun Rev; 2008 Jan; 7(3):168-73. PubMed ID: 18190873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An overview of the immune mechanisms of viral myocarditis.
    Lasrado N; Reddy J
    Rev Med Virol; 2020 Nov; 30(6):1-14. PubMed ID: 32720461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocarditis as systemic disease: new perspectives on pathogenesis.
    Carthy CM; Yang D; Anderson DR; Wilson JE; McManus BM
    Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):997-1003. PubMed ID: 9406676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pathogenesis of inflammatory cardiomyopathies].
    Schultheiss HP; Pauschinger M; Kühl U
    Med Klin (Munich); 1998 Apr; 93(4):229-35. PubMed ID: 9594532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation.
    Kandolf R; Klingel K; Zell R; Selinka HC; Raab U; Schneider-Brachert W; Bültmann B
    Intervirology; 1993; 35(1-4):140-51. PubMed ID: 8407241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates.
    Stone VM; Hankaniemi MM; Laitinen OH; Sioofy-Khojine AB; Lin A; Diaz Lozano IM; Mazur MA; Marjomäki V; Loré K; Hyöty H; Hytönen VP; Flodström-Tullberg M
    Sci Adv; 2020 May; 6(19):eaaz2433. PubMed ID: 32494709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitochondrial extracellular vesicles, autoimmunity and myocarditis.
    Di Florio DN; Beetler DJ; McCabe EJ; Sin J; Ikezu T; Fairweather D
    Front Immunol; 2024; 15():1374796. PubMed ID: 38550582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.